Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Relaxation and Heart Rate Variability
This study has been completed.
Sponsored by: M.D. Anderson Cancer Center
Information provided by: M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier: NCT00735618
  Purpose

Primary:

  • To characterize the physiologic changes of the autonomic nervous system, demonstrated by heart rate variability (HRV) high frequency (HF) spectral analysis, before and after a 15 minute, one-time, guided relaxation program for cancer patients.

Secondary:

  • To assess whether change of HRV correlates with subjective feeling for anxiety, based on visual analog scale scores.

Condition Intervention
Cancer
Other: Guided Relaxation
Other: HRV HF spectral analysis

MedlinePlus related topics: Anxiety Cancer
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Open Label, Single Group Assignment
Official Title: Pilot Study on the Effects of a Brief Relaxation Program on Heart Rate Variability in Cancer Patients

Further study details as provided by M.D. Anderson Cancer Center:

Primary Outcome Measures:
  • To learn how rhythm changes in heart rate (a function of the nervous system) are affected by a 15-minute "guided relaxation" session. [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 20
Study Start Date: June 2008
Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Individuals who have cancer now or had cancer in the past
Other: Guided Relaxation
Following 5 minute questionnaire, 15 minute rest and 5 minute heart rhythm recording, 15 minute relaxation program (listening via headphone to audio recording) to be completed by second heart rhythm recording and same questionnaire. Entire procedure 45-60 minutes.
Other: HRV HF spectral analysis

Heart Rate Variability (HRV) High frequency (HF) spectral analysis:

Following 15 minute rest, 5 minute HRV recording (HF spectral analysis) electrodes placed along chest (same way as electrocardiogram). Procedure repeated after relaxation program for second 5 minute recording.


Detailed Description:

Rhythm changes in your heart rate are part of the "autonomic" nervous system. This is the part of your nervous system that controls the body functions that you do not have to think about. Researchers want to find out if a "guided relaxation" session will make your heart rate more variable, with more rhythm changes.

If you are found to be eligible to take part in this study, you will first answer a brief questionnaire that will measure several symptoms, such as pain and anxiety (worry). This questionnaire will take less than 5 minutes. You will also be asked questions about your alcohol and smoking history, and if you have ever used relaxation or meditation techniques in the past. This will also take less than 5 minutes.

You will then be asked to lay on your back, on a hospital bed or exam table. Electrodes will be placed along your chest, the same way they are placed for an electrocardiogram (ECG--a test to measure the electrical activity of the heart). You will be asked to rest for 15 minutes, and then your heart rhythm will be recorded for 5 minutes. After this first recording, you will begin the relaxation program by listening to an audio recording for about 15 minutes, using headphones. After the relaxation program has ended, your heart rhythm will be recorded for another 5-minute period while you are resting.

You will then be asked to complete the same questionnaire as before.

The entire procedure will take about 45-60 minutes. After this second questionnaire, your participation on this study will be over.

This is an investigational study. Up to 20 people will take part in this study. All will be enrolled at M. D. Anderson.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Written informed consent
  2. Normal cognition (per treating physician's assessment)

Exclusion Criteria:

  1. Dementia
  2. Psychosis
  3. Delirium
  4. Not fluent in English
  5. Cardiac dysrhythmia
  6. Inability to lay supine
  7. Pacemaker
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00735618

Locations
United States, Texas
U. T. M.D. Anderson Cancer Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
M.D. Anderson Cancer Center
Investigators
Principal Investigator: Ying Guo, MD U.T. M.D. Anderson Cancer Center Professor
  More Information

U.T. M.D. Anderson Cancer Center  This link exits the ClinicalTrials.gov site

Responsible Party: U.T. M. D. Anderson Cancer Center ( Ying Guo, MD, MS, Assistant Professor )
Study ID Numbers: 2008-0028
Study First Received: August 12, 2008
Last Updated: October 22, 2008
ClinicalTrials.gov Identifier: NCT00735618  
Health Authority: United States: Institutional Review Board

Keywords provided by M.D. Anderson Cancer Center:
Advanced Cancer
Cancer Patients
Relaxation Therapy
Relaxation and Heart Rate Variability
Guided Relaxation
HRV
Stress, Anxiety, and Panic Disorder

Study placed in the following topic categories:
Panic Disorder
Stress

ClinicalTrials.gov processed this record on January 16, 2009